Guide: Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm (European Union): Difference between revisions
(Created page with "'''Sponsor, manager or home institution:''' WHO Regional Office for Europe. '''Primary purpose:''' To provide guidance to policy-makers and public health leads in the WHO European Region on planning, designing, and implementing effective screening programs while considering evidence-based decision-making, quality assurance, and minimizing potential harm, costs, and burdens on the healthcare system. '''Type of information:''' Aims of screening programmes; Wilson & Jungn...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{forpolicymakers}} | |||
{{forproviders}} | |||
'''Sponsor, manager or home institution:''' WHO Regional Office for Europe. | '''Sponsor, manager or home institution:''' WHO Regional Office for Europe. | ||
Revision as of 16:30, 30 November 2023
Sponsor, manager or home institution: WHO Regional Office for Europe.
Primary purpose: To provide guidance to policy-makers and public health leads in the WHO European Region on planning, designing, and implementing effective screening programs while considering evidence-based decision-making, quality assurance, and minimizing potential harm, costs, and burdens on the healthcare system.
Type of information: Aims of screening programmes; Wilson & Jungner’s principles of screening; Screening programmes as pathways; Understanding how screening tests work in practice; Benefits and harm of screening; Balancing benefits and harm; Deciding whether to start or stop a screening programme; Designing effective screening programmes; Operational readiness; Operating a screening programme; Monitoring and evaluation.
Data level: European level.
Access to information: Access Information [1].
